{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:24:35Z","timestamp":1755224675714,"version":"3.43.0"},"reference-count":73,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Although several physiologically based pharmacokinetic (PBPK) models exist for ethylbenzene (EB), a systematic evaluation of variability and uncertainty across species is still missing. This study aims to develop and validate a universal, population-based Bayesian PBPK model to study EB inhalation kinetics for mice, rats, and humans using a Markov Chain Monte Carlo (MCMC) approach to enhance model parameterization and its predictions. A comprehensive database was used for calibration and evaluation. This refined model demonstrates a superior or comparable fit to the data when contrasted with earlier published PBPK models for EB. Except for mouse fat and lung tissues, the concentrations of EB in tissues and its metabolites were generally within residual errors of 3-fold across species. Specifically, urinary concentrations of mandelic acid, the primary downstream metabolite of EB, are generally well predicted in both rats and humans. Our approach offers a better characterization of pharmacokinetic variability and uncertainty than previous EB models, with strong agreement between predictions and experimental data. This supports efforts to adopt PBPK modeling for data extrapolation from animal studies to inform human health assessments, thereby greatly promoting public health. The confidence in applying the current refined PBPK model could be increased by confirming the predictions made by our analysis with additional targeted data collection.<\/jats:p>\n               <jats:p>Impact Statement: This study presents a refined Bayesian PBPK model that captures EB pharmacokinetics across species. It outperforms previous EB models and improves interspecies extrapolation for human health risk assessment.<\/jats:p>","DOI":"10.1093\/toxsci\/kfaf070","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T08:24:35Z","timestamp":1747297475000},"page":"233-252","source":"Crossref","is-referenced-by-count":0,"title":["Bayesian refinement of a physiologically based pharmacokinetic model for ethylbenzene pharmacokinetics in mice, rats, and humans"],"prefix":"10.1093","volume":"206","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6813-7826","authenticated-orcid":false,"given":"Yu-Sheng","family":"Lin","sequence":"first","affiliation":[{"name":"Office of Research and Development, U.S. EPA , Washington, DC 20460,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0163-2766","authenticated-orcid":false,"given":"Nan-Hung","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Department of Veterinary Physiology and Pharmacology, Texas A&M University , College Station, TX 77843,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9699-9108","authenticated-orcid":false,"given":"Paul M","family":"Schlosser","sequence":"additional","affiliation":[{"name":"Office of Research and Development, U.S. EPA , Washington, DC 20460,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7010-6191","authenticated-orcid":false,"given":"Michael W","family":"Dzierlenga","sequence":"additional","affiliation":[{"name":"Office of Research and Development, U.S. EPA , Washington, DC 20460,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0073-128X","authenticated-orcid":false,"given":"Hyunsu","family":"Ju","sequence":"additional","affiliation":[{"name":"Office of Research and Development, U.S. EPA , Washington, DC 20460,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"volume-title":"Voluntary children\u2019s chemical evaluation program (VCCEP): ethylbenzene peer consultation meeting report: revised appendices P-R","year":"2007","author":"ACC","key":"2025081219525350000_kfaf070-B1"},{"key":"2025081219525350000_kfaf070-B2","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1539-6924.2007.00934.x","article-title":"Use of Markov Chain Monte Carlo analysis with a physiologically-based pharmacokinetic model of methylmercury to estimate exposures in us women of childbearing age","volume":"27","author":"Allen","year":"2007","journal-title":"Risk Anal"},{"key":"2025081219525350000_kfaf070-B3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00378152","article-title":"Occupational chronic exposure to organic-solvents: 8. Phenolic compounds-metabolites of alkylbenzenes in man\u2014simultaneous exposure to ethylbenzene and xylenes","volume":"43","author":"Angerer","year":"1979","journal-title":"Int Arch Occup Environ Health"},{"volume-title":"Toxicological profile for ethylbenzene","year":"2010","author":"ATSDR","key":"2025081219525350000_kfaf070-B4"},{"key":"2025081219525350000_kfaf070-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/taap.1999.8656","article-title":"Changes in the expression of cytochrome p450s 2b1, 2b2, 2e1, and 2c11 in response to daily aromatic hydrocarbon treatment","volume":"157","author":"Bergeron","year":"1999","journal-title":"Toxicol Appl Pharmacol"},{"key":"2025081219525350000_kfaf070-B6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1289\/ehp.00108s2275","article-title":"Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics","volume":"108","author":"Bois","year":"2000","journal-title":"Environ Health Perspect"},{"key":"2025081219525350000_kfaf070-B7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1289\/ehp.00108s2307","article-title":"Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics","volume":"108","author":"Bois","year":"2000","journal-title":"Environ Health Perspect"},{"key":"2025081219525350000_kfaf070-B8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/978-1-62703-059-5_25","article-title":"Bayesian inference","volume":"930","author":"Bois","year":"2013","journal-title":"Methods Mol Biol"},{"key":"2025081219525350000_kfaf070-B9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/074823379701300401","article-title":"Physiological parameter values for physiologically based pharmacokinetic models","volume":"13","author":"Brown","year":"1997","journal-title":"Toxicol Ind Health"},{"key":"2025081219525350000_kfaf070-B10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0892-0362(02)00208-8","article-title":"Differential susceptibility of rats and guinea pigs to the ototoxic effects of ethyl benzene","volume":"24","author":"Cappaert","year":"2002","journal-title":"Neurotoxicol Teratol"},{"key":"2025081219525350000_kfaf070-B11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0378-4274(98)00133-7","article-title":"Tumor induction in f344\/n rats and b6c3f1 mice following inhalation exposure to ethylbenzene","volume":"99","author":"Chan","year":"1998","journal-title":"Toxicol Lett"},{"key":"2025081219525350000_kfaf070-B12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.taap.2005.07.001","article-title":"Inhalation pharmacokinetics of ethylbenzene in b6c3f1 mice","volume":"210","author":"Charest-Tardif","year":"2006","journal-title":"Toxicol Appl Pharmacol"},{"key":"2025081219525350000_kfaf070-B13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.taap.2011.03.020","article-title":"Development and evaluation of a harmonized physiologically based pharmacokinetic (PBPK) model for perchloroethylene toxicokinetics in mice, rats, and humans","volume":"253","author":"Chiu","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"2025081219525350000_kfaf070-B14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.taap.2009.07.032","article-title":"Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach","volume":"241","author":"Chiu","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"2025081219525350000_kfaf070-B15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12989-022-00489-4","article-title":"Development of a multi-route physiologically based pharmacokinetic (PBPK) model for nanomaterials: a comparison between a traditional versus a new route-specific approach using gold nanoparticles in rats","volume":"19","author":"Chou","year":"2022","journal-title":"Part Fibre Toxicol"},{"key":"2025081219525350000_kfaf070-B16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.envint.2019.03.058","article-title":"Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: development and performance verification","volume":"129","author":"Chou","year":"2019","journal-title":"Environ Int"},{"key":"2025081219525350000_kfaf070-B17","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/00498258309052221","article-title":"The metabolism of ethylbenzene hydroperoxide in the rat","volume":"13","author":"Climie","year":"1983","journal-title":"Xenobiotica"},{"key":"2025081219525350000_kfaf070-B18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yrtph.2009.07.002","article-title":"Mouse specific lung tumors from CYP2f2-mediated cytotoxic metabolism: an endpoint\/toxic response where data from multiple chemicals converge to support a mode of action","volume":"55","author":"Cruzan","year":"2009","journal-title":"Regul Toxicol Pharmacol"},{"key":"2025081219525350000_kfaf070-B19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.taap.2018.05.033","article-title":"Incorporation of the glutathione conjugation pathway in an updated physiologically-based pharmacokinetic model for perchloroethylene in mice","volume":"352","author":"Dalaijamts","year":"2018","journal-title":"Toxicol Appl Pharmacol"},{"key":"2025081219525350000_kfaf070-B20","doi-asserted-by":"crossref","first-page":"115069","DOI":"10.1016\/j.taap.2020.115069","article-title":"PBPK modeling of impact of nonalcoholic fatty liver disease on toxicokinetics of perchloroethylene in mice","volume":"400","author":"Dalaijamts","year":"2020","journal-title":"Toxicol Appl Pharmacol"},{"key":"2025081219525350000_kfaf070-B21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.etap.2003.10.003","article-title":"PBPK modeling of complex hydrocarbon mixtures: gasoline","volume":"16","author":"Dennison","year":"2004","journal-title":"Environ Toxicol Pharmacol"},{"key":"2025081219525350000_kfaf070-B22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/00498258509045364","article-title":"Biochemical and morphological effects of long-term inhalation exposure of rats to ethylbenzene","volume":"15","author":"Elovaara","year":"1985","journal-title":"Xenobiotica"},{"key":"2025081219525350000_kfaf070-B23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00378589","article-title":"Urinary disposition of ethylbenzene and m-xylene in man following separate and combined exposure","volume":"54","author":"Engstr\u00f6m","year":"1984","journal-title":"Int Arch Occup Environ Health"},{"key":"2025081219525350000_kfaf070-B24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5271\/sjweh.2354","article-title":"Metabolism of inhaled ethylbenzene in rats","volume":"10","author":"Engstr\u00f6m","year":"1984","journal-title":"Scand J Work Environ Health"},{"volume-title":"Ethylbenzene two-week repeated-dose inhalation toxicokinetic study report","year":"2000","author":"Fuciarelli","key":"2025081219525350000_kfaf070-B25"},{"key":"2025081219525350000_kfaf070-B26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00204-006-0124-y","article-title":"Ototoxicity in rats exposed to ethylbenzene and to two technical xylene vapours for 13 weeks","volume":"81","author":"Gagnaire","year":"2007","journal-title":"Arch Toxicol"},{"key":"2025081219525350000_kfaf070-B27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1214\/06-BA117A","article-title":"Prior distributions for variance parameters in hierarchical models (comment on an article by Browne and Draper)","volume":"1","author":"Gelman","year":"2006","journal-title":"Bayesian Anal"},{"key":"2025081219525350000_kfaf070-B28","doi-asserted-by":"crossref","DOI":"10.1201\/9780429258480","volume-title":"Bayesian data analysis","author":"Gelman","year":"2003"},{"key":"2025081219525350000_kfaf070-B29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/15287394.2016.1169237","article-title":"Effect of genetic strain and gender on age-related changes in body composition of the laboratory rat","volume":"79","author":"Gordon","year":"2016","journal-title":"J Toxicol Environ Health A"},{"key":"2025081219525350000_kfaf070-B30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/faat.1997.2312","article-title":"Trichloroethylene-induced mouse lung tumors: studies of the mode of action and comparisons between species","volume":"37","author":"Green","year":"1997","journal-title":"Fundam Appl Toxicol"},{"key":"2025081219525350000_kfaf070-B31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00378068","article-title":"Urinary mandelic acid as an exposure test for ethylbenzene","volume":"55","author":"Gromiec","year":"1984","journal-title":"Int Arch Occup Environ Health"},{"key":"2025081219525350000_kfaf070-B32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yrtph.2006.05.012","article-title":"Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites","volume":"46","author":"Hack","year":"2006","journal-title":"Regul Toxicol Pharmacol"},{"key":"2025081219525350000_kfaf070-B33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/00984100050131350","article-title":"Physiologically based modeling of the maximal effect of metabolic interactions on the kinetics of components of complex chemical mixtures","volume":"61","author":"Haddad","year":"2000","journal-title":"J Toxicol Environ Health A"},{"key":"2025081219525350000_kfaf070-B34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/taap.2000.8991","article-title":"Validation of a physiological modeling framework for simulating the toxicokinetics of chemicals in mixtures","volume":"167","author":"Haddad","year":"2000","journal-title":"Toxicol Appl Pharmacol"},{"key":"2025081219525350000_kfaf070-B35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/taap.1999.8803","article-title":"Physiological modeling of the toxicokinetic interactions in a quaternary mixture of aromatic hydrocarbons","volume":"161","author":"Haddad","year":"1999","journal-title":"Toxicol Appl Pharmacol"},{"key":"2025081219525350000_kfaf070-B36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0378-4274(99)00102-2","article-title":"A modeling approach to account for toxicokinetic interactions in the calculation of biological hazard index for chemical mixtures","volume":"108","author":"Haddad","year":"1999","journal-title":"Toxicol Lett"},{"key":"2025081219525350000_kfaf070-B37","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10928-021-09778-5","article-title":"A Bayesian population physiologically based pharmacokinetic absorption modeling approach to support generic drug development: application to bupropion hydrochloride oral dosage forms","volume":"48","author":"Hsieh","year":"2021","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"2025081219525350000_kfaf070-B38","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3389\/fphar.2018.00588","article-title":"Applying a global sensitivity analysis workflow to improve the computational efficiencies in physiologically-based pharmacokinetic modeling","volume":"9","author":"Hsieh","year":"2018","journal-title":"Front Pharmacol"},{"key":"2025081219525350000_kfaf070-B39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00420-007-0233-9","article-title":"Excretion of unchanged volatile organic compounds (toluene, ethylbenzene, xylene and mesitylene) in urine as result of experimental human volunteer exposure","volume":"81","author":"Janasik","year":"2008","journal-title":"Int Arch Occup Environ Health"},{"key":"2025081219525350000_kfaf070-B40","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1021\/bi00766a022","article-title":"Arene oxides as intermediates in the oxidative metabolism of aromatic compounds isomerization of methyl-substituted arene oxides","volume":"11","author":"Kaubisch","year":"1972","journal-title":"Biochemistry"},{"key":"2025081219525350000_kfaf070-B41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yrtph.2005.01.002","article-title":"Effects of styrene and its metabolites on different lung compartments of the mouse\u2014cell proliferation and histomorphology","volume":"42","author":"Kaufmann","year":"2005","journal-title":"Regul Toxicol Pharmacol"},{"key":"2025081219525350000_kfaf070-B42","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s002040050018","article-title":"Biological monitoring of standardized exposure to ethylbenzene: evaluation of a biological tolerance (BAT) value","volume":"73","author":"Knecht","year":"2000","journal-title":"Arch Toxicol"},{"key":"2025081219525350000_kfaf070-B43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.jes.7500635","article-title":"Relationships between levels of volatile organic compounds in air and blood from the general population","volume":"18","author":"Lin","year":"2008","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"2025081219525350000_kfaf070-B44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/10408440490265210","article-title":"Chemically induced renal tubule tumors in the laboratory rat and mouse: review of the NCI\/NTP database and categorization of renal carcinogens based on mechanistic information","volume":"34","author":"Lock","year":"2004","journal-title":"Crit Rev Toxicol"},{"key":"2025081219525350000_kfaf070-B45","doi-asserted-by":"crossref","first-page":"e1004495","DOI":"10.1371\/journal.pcbi.1004495","article-title":"Developing a physiologically-based pharmacokinetic model knowledgebase in support of provisional model construction","volume":"12","author":"Lu","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"2025081219525350000_kfaf070-B46","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/toxsci\/kfv009","article-title":"Human inhalation exposures to toluene, ethylbenzene, and m-xylene and physiologically based pharmacokinetic modeling of exposure biomarkers in exhaled air, blood, and urine","volume":"144","author":"Marchand","year":"2015","journal-title":"Toxicol Sci"},{"key":"2025081219525350000_kfaf070-B47","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/08958378.2016.1162232","article-title":"Evaluation and modeling of the impact of coexposures to voc mixtures on urinary biomarkers","volume":"28","author":"Marchand","year":"2016","journal-title":"Inhal Toxicol"},{"key":"2025081219525350000_kfaf070-B48","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/toxsci\/54.1.222","article-title":"Uptake of styrene in the upper respiratory tract of the CD mouse and Sprague-Dawley rat","volume":"54","author":"Morris","year":"2000","journal-title":"Toxicol Sci"},{"key":"2025081219525350000_kfaf070-B49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1539\/joh.39.83","article-title":"Cytochrome p450 isoforms and the metabolism of volatile hydrocarbons of low relative molecular mass","volume":"39","author":"Nakajima","year":"1997","journal-title":"J Occup Health"},{"key":"2025081219525350000_kfaf070-B50","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1021\/tx00042a026","article-title":"Styrene metabolism by CDNA-expressed human hepatic and pulmonary cytochromes p450","volume":"7","author":"Nakajima","year":"1994","journal-title":"Chem Res Toxicol"},{"volume-title":"Butadiene and styrene: assessment of health hazards characterization of the human cytochrome p450 isozymes responsible for styrene metabolism","year":"1993","author":"Nakajima","key":"2025081219525350000_kfaf070-B51"},{"key":"2025081219525350000_kfaf070-B52","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1021\/bi00475a012","article-title":"The human CYP2f gene subfamily: identification of a CDNA encoding a new cytochrome p450, CDNA-directed expression, and chromosome mapping","volume":"29","author":"Nhamburo","year":"1990","journal-title":"Biochemistry"},{"key":"2025081219525350000_kfaf070-B53","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1080\/15287390701459239","article-title":"Physiologically based modeling of the inhalation pharmacokinetics of ethylbenzene in B6c3f1 mice","volume":"70","author":"Nong","year":"2007","journal-title":"J Toxicol Environ Health A"},{"first-page":"99","year":"1999","author":"NTP","key":"2025081219525350000_kfaf070-B54"},{"key":"2025081219525350000_kfaf070-B55","first-page":"95","article-title":"Durational effects of ethylbenzene exposure on its metabolism in rats","volume":"42","author":"Pedersen","year":"1998","journal-title":"Toxicol Sci"},{"key":"2025081219525350000_kfaf070-B56","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0300-483X(99)00134-1","article-title":"Species comparison of hepatic and pulmonary metabolism of benzene","volume":"139","author":"Powley","year":"1999","journal-title":"Toxicology"},{"key":"2025081219525350000_kfaf070-B57","first-page":"156","article-title":"Tissue and species differences in metabolism of ethylbenzene","volume":"38","author":"Saghir","year":"2006","journal-title":"Drug Metab Rev"},{"key":"2025081219525350000_kfaf070-B58","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/toxsci\/kfn244","article-title":"Mechanism of ethylbenzene-induced mouse-specific lung tumor: metabolism of ethylbenzene by rat, mouse, and human liver and lung microsomes","volume":"107","author":"Saghir","year":"2009","journal-title":"Toxicol Sci"},{"key":"2025081219525350000_kfaf070-B59","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.yrtph.2010.01.003","article-title":"In vitro metabolism and covalent binding of ethylbenzene to microsomal protein as a possible mechanism of ethylbenzene-induced mouse lung tumorigenesis","volume":"57","author":"Saghir","year":"2010","journal-title":"Regul Toxicol Pharmacol"},{"key":"2025081219525350000_kfaf070-B60","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.toxlet.2003.11.010","article-title":"Metabolism of ethylbenzene by human liver microsomes and recombinant human cytochrome p450s (CYP)","volume":"147","author":"Sams","year":"2004","journal-title":"Toxicol Lett"},{"key":"2025081219525350000_kfaf070-B61","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/08958370290084656","article-title":"Comparing respiratory-tract and hepatic exposure-dose relationships for metabolized inhaled vapors: a pharmacokinetic analysis","volume":"14","author":"Sarangapani","year":"2002","journal-title":"Inhal Toxicol"},{"key":"2025081219525350000_kfaf070-B62","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/009841099157917","article-title":"Organ weights and fat volume in rats as a function of strain and age","volume":"56","author":"Schoeffner","year":"1999","journal-title":"J Toxicol Environ Health A"},{"key":"2025081219525350000_kfaf070-B63","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/taap.2000.8910","article-title":"Ethylbenzene induces microsomal oxygen free radical generation: antibody-directed characterization of the responsible cytochrome p450 enzymes","volume":"164","author":"Serron","year":"2000","journal-title":"Toxicol Appl Pharmacol"},{"key":"2025081219525350000_kfaf070-B64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/toxsci\/71.1.53","article-title":"Evaluation of potential modes of action of inhaled ethylbenzene in rats and mice","volume":"71","author":"Stott","year":"2003","journal-title":"Toxicol Sci"},{"key":"2025081219525350000_kfaf070-B65","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3109\/10408444.2015.1046157","article-title":"Risk assessments for chronic exposure of children and prospective parents to ethylbenzene (CAS No. 100-41-4)","volume":"45","author":"Sweeney","year":"2015","journal-title":"Crit Rev Toxicol"},{"key":"2025081219525350000_kfaf070-B66","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1080\/10934529.2020.1827653","article-title":"Area under the blood concentration-time curve (AUC) of ethylbenzene concentration in rats: relationship to inhalation and oral administration route-dose","volume":"55","author":"Take","year":"2020","journal-title":"J Environ Sci Health A Tox Hazard Subst Environ Eng"},{"key":"2025081219525350000_kfaf070-B67","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s002040050292","article-title":"Comparison of the influence of binary mixtures versus a ternary mixture of inhaled aromatic hydrocarbons on their blood kinetics in the rat","volume":"70","author":"Tardif","year":"1996","journal-title":"Arch Toxicol"},{"key":"2025081219525350000_kfaf070-B68","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1006\/taap.1996.8096","article-title":"Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans","volume":"144","author":"Tardif","year":"1997","journal-title":"Toxicol Appl Pharmacol"},{"year":"2011","author":"U.S. EPA","key":"2025081219525350000_kfaf070-B69"},{"volume-title":"Toxicological review of tetrachloroethylene (perchloroethylene) (CASRN 127-18-4) in support of summary information on the integrated risk information system (IRIS).","year":"2012","author":"U.S. EPA","key":"2025081219525350000_kfaf070-B70"},{"year":"2022","author":"U.S. EPA","key":"2025081219525350000_kfaf070-B770"},{"key":"2025081219525350000_kfaf070-B71","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0013-9351(89)80047-7","article-title":"The influence of personal activities on exposure to volatile organic compounds","volume":"50","author":"Wallace","year":"1989","journal-title":"Environ Res"},{"key":"2025081219525350000_kfaf070-B72","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.chemosphere.2013.09.019","article-title":"Lifetime PCB 153 bioaccumulation and pharmacokinetics in pilot whales: Bayesian population PBPK modeling and Markov chain Monte Carlo simulations","volume":"94","author":"Weijs","year":"2014","journal-title":"Chemosphere"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/toxsci\/advance-article-pdf\/doi\/10.1093\/toxsci\/kfaf070\/63212602\/kfaf070.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/toxsci\/article-pdf\/206\/2\/233\/63212602\/kfaf070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/toxsci\/article-pdf\/206\/2\/233\/63212602\/kfaf070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T23:53:07Z","timestamp":1755042787000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/206\/2\/233\/8133955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":73,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,5,19]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfaf070","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"type":"print","value":"1096-6080"},{"type":"electronic","value":"1096-0929"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,5,19]]}}}